A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new potential therapeutic target. A ...

Shares in MeiraGTx rose after the company said it received positive data in a clinical bridging study of AAV-GAD for the treatment of Parkinson's disease. Shares were up nearly 14% in premarket ...

Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ...

30, 2024 — Researchers have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with no cure and few ...

19, 2024 — A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease ...

This article reviews the symptoms, diagnosis, risk factors, and treatment of Parkinson's disease dementia. It also helps distinguish PDD from dementia with Lewy bodies (DLB), a condition with ...

MeiraGTx Holdings (NASDAQ:MGTX) added ~14% in the premarket on Tuesday after the New York-based biotech announced promising ...

According to a recent study, a new drug molecule could lead to preventive treatments for early onset Parkinson's disease.

The technology is part of a broader industry shift towards precision medicine, says GlobalData analyst Cynthia Stinchcombe.

The project, which will be conducted by URMC’s Center for Health + Technology, seeks to create objective, digital tools that can provide a clearer picture of how Huntington’s disease advances, ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...